CARPENTER TECHNOLOGY (CRS) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:CRS - US1442851036 - Common Stock
327.99 USD
-0.66 (-0.2%)
Taking everything into account, CRS scores 7 out of 10 in our fundamental rating. CRS was compared to 71 industry peers in the Aerospace & Defense industry. CRS scores excellent points on both the profitability and health parts. This is a solid base for a good stock. CRS has a correct valuation and a medium growth rate. These ratings would make CRS suitable for quality investing!
1. Profitability
1.1 Basic Checks
CRS had positive earnings in the past year.
CRS had a positive operating cash flow in the past year.
In multiple years CRS reported negative net income over the last 5 years.
In the past 5 years CRS always reported a positive cash flow from operatings.
1.2 Ratios
CRS has a Return On Assets of 12.15%. This is amongst the best in the industry. CRS outperforms 94.37% of its industry peers.
CRS has a better Return On Equity (21.64%) than 88.73% of its industry peers.
CRS has a better Return On Invested Capital (15.64%) than 95.77% of its industry peers.
CRS had an Average Return On Invested Capital over the past 3 years of 9.88%. This is in line with the industry average of 8.54%.
The 3 year average ROIC (9.88%) for CRS is below the current ROIC(15.64%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 12.15% | ||
| ROE | 21.64% | ||
| ROIC | 15.64% |
ROA(3y)6.09%
ROA(5y)1.77%
ROE(3y)11.79%
ROE(5y)3.03%
ROIC(3y)9.88%
ROIC(5y)N/A
1.3 Margins
CRS's Profit Margin of 14.29% is amongst the best of the industry. CRS outperforms 90.14% of its industry peers.
CRS's Profit Margin has improved in the last couple of years.
CRS's Operating Margin of 19.40% is amongst the best of the industry. CRS outperforms 90.14% of its industry peers.
CRS's Operating Margin has improved in the last couple of years.
CRS has a Gross Margin of 27.95%. This is in the better half of the industry: CRS outperforms 60.56% of its industry peers.
CRS's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 19.4% | ||
| PM (TTM) | 14.29% | ||
| GM | 27.95% |
OM growth 3YN/A
OM growth 5Y20.36%
PM growth 3YN/A
PM growth 5Y203.85%
GM growth 3Y48.5%
GM growth 5Y10.19%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so CRS is still creating some value.
Compared to 1 year ago, CRS has about the same amount of shares outstanding.
Compared to 5 years ago, CRS has more shares outstanding
The debt/assets ratio for CRS has been reduced compared to a year ago.
2.2 Solvency
CRS has an Altman-Z score of 9.19. This indicates that CRS is financially healthy and has little risk of bankruptcy at the moment.
CRS has a Altman-Z score of 9.19. This is in the better half of the industry: CRS outperforms 77.46% of its industry peers.
CRS has a debt to FCF ratio of 2.58. This is a good value and a sign of high solvency as CRS would need 2.58 years to pay back of all of its debts.
CRS's Debt to FCF ratio of 2.58 is amongst the best of the industry. CRS outperforms 85.92% of its industry peers.
CRS has a Debt/Equity ratio of 0.36. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of CRS (0.36) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.36 | ||
| Debt/FCF | 2.58 | ||
| Altman-Z | 9.19 |
ROIC/WACC1.65
WACC9.5%
2.3 Liquidity
A Current Ratio of 4.44 indicates that CRS has no problem at all paying its short term obligations.
CRS has a better Current ratio (4.44) than 80.28% of its industry peers.
CRS has a Quick Ratio of 2.37. This indicates that CRS is financially healthy and has no problem in meeting its short term obligations.
CRS has a better Quick ratio (2.37) than 70.42% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 4.44 | ||
| Quick Ratio | 2.37 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 46.33% over the past year.
Measured over the past years, CRS shows a very strong growth in Earnings Per Share. The EPS has been growing by 27.85% on average per year.
Looking at the last year, CRS shows a small growth in Revenue. The Revenue has grown by 2.40% in the last year.
CRS shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.70% yearly.
EPS 1Y (TTM)46.33%
EPS 3YN/A
EPS 5Y27.85%
EPS Q2Q%40.46%
Revenue 1Y (TTM)2.4%
Revenue growth 3Y16.15%
Revenue growth 5Y5.7%
Sales Q2Q%2.24%
3.2 Future
Based on estimates for the next years, CRS will show a quite strong growth in Earnings Per Share. The EPS will grow by 15.01% on average per year.
The Revenue is expected to grow by 5.66% on average over the next years.
EPS Next Y30.75%
EPS Next 2Y25.52%
EPS Next 3Y20.5%
EPS Next 5Y15.01%
Revenue Next Year4.4%
Revenue Next 2Y6.66%
Revenue Next 3Y6.85%
Revenue Next 5Y5.66%
3.3 Evolution
The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 40.10, CRS can be considered very expensive at the moment.
Based on the Price/Earnings ratio, CRS is valued a bit cheaper than the industry average as 64.79% of the companies are valued more expensively.
CRS is valuated rather expensively when we compare the Price/Earnings ratio to 27.19, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 27.83, CRS can be considered very expensive at the moment.
76.06% of the companies in the same industry are more expensive than CRS, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 23.92. CRS is around the same levels.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 40.1 | ||
| Fwd PE | 27.83 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, CRS is valued a bit cheaper than 63.38% of the companies in the same industry.
CRS's Price/Free Cash Flow ratio is in line with the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 60.65 | ||
| EV/EBITDA | 23.99 |
4.3 Compensation for Growth
CRS's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The excellent profitability rating of CRS may justify a higher PE ratio.
A more expensive valuation may be justified as CRS's earnings are expected to grow with 20.50% in the coming years.
PEG (NY)1.3
PEG (5Y)1.44
EPS Next 2Y25.52%
EPS Next 3Y20.5%
5. Dividend
5.1 Amount
CRS has a yearly dividend return of 0.25%, which is pretty low.
Compared to an average industry Dividend Yield of 0.37, CRS pays a bit more dividend than its industry peers.
With a Dividend Yield of 0.25, CRS pays less dividend than the S&P500 average, which is at 1.92.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.25% |
5.2 History
The dividend of CRS decreases each year by -0.08%.
CRS has paid a dividend for at least 10 years, which is a reliable track record.
CRS has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)-0.08%
Div Incr Years0
Div Non Decr Years21
5.3 Sustainability
CRS pays out 9.75% of its income as dividend. This is a sustainable payout ratio.
DP9.75%
EPS Next 2Y25.52%
EPS Next 3Y20.5%
NYSE:CRS (1/12/2026, 2:20:28 PM)
327.99
-0.66 (-0.2%)
Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)
Earnings (Next)
Inst Owners97.76%
Inst Owner Change0.12%
Ins Owners2.43%
Ins Owner Change4.95%
Market Cap16.34B
Revenue(TTM)2.89B
Net Income(TTM)413.50M
Analysts83.33
Price Target360.39 (9.88%)
Short Float %6.7%
Short Ratio3.37
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.25% |
Yearly Dividend0.81
Dividend Growth(5Y)-0.08%
DP9.75%
Div Incr Years0
Div Non Decr Years21
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)8.39%
Min EPS beat(2)5.81%
Max EPS beat(2)10.98%
EPS beat(4)4
Avg EPS beat(4)6.6%
Min EPS beat(4)2.34%
Max EPS beat(4)10.98%
EPS beat(8)7
Avg EPS beat(8)9.84%
EPS beat(12)11
Avg EPS beat(12)11.68%
EPS beat(16)15
Avg EPS beat(16)17.18%
Revenue beat(2)0
Avg Revenue beat(2)-4.21%
Min Revenue beat(2)-5.61%
Max Revenue beat(2)-2.81%
Revenue beat(4)0
Avg Revenue beat(4)-4.21%
Min Revenue beat(4)-7.04%
Max Revenue beat(4)-1.38%
Revenue beat(8)1
Avg Revenue beat(8)-3.48%
Revenue beat(12)4
Avg Revenue beat(12)-1.82%
Revenue beat(16)7
Avg Revenue beat(16)0.16%
PT rev (1m)0%
PT rev (3m)19.89%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0.68%
EPS NY rev (1m)0.16%
EPS NY rev (3m)-1.24%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.42%
Revenue NY rev (1m)0.03%
Revenue NY rev (3m)-2.83%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 40.1 | ||
| Fwd PE | 27.83 | ||
| P/S | 5.65 | ||
| P/FCF | 60.65 | ||
| P/OCF | 37.19 | ||
| P/B | 8.55 | ||
| P/tB | 9.75 | ||
| EV/EBITDA | 23.99 |
EPS(TTM)8.18
EY2.49%
EPS(NY)11.78
Fwd EY3.59%
FCF(TTM)5.41
FCFY1.65%
OCF(TTM)8.82
OCFY2.69%
SpS58.07
BVpS38.36
TBVpS33.64
PEG (NY)1.3
PEG (5Y)1.44
Graham Number84.03
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 12.15% | ||
| ROE | 21.64% | ||
| ROCE | 18.56% | ||
| ROIC | 15.64% | ||
| ROICexc | 16.8% | ||
| ROICexgc | 18.33% | ||
| OM | 19.4% | ||
| PM (TTM) | 14.29% | ||
| GM | 27.95% | ||
| FCFM | 9.31% |
ROA(3y)6.09%
ROA(5y)1.77%
ROE(3y)11.79%
ROE(5y)3.03%
ROIC(3y)9.88%
ROIC(5y)N/A
ROICexc(3y)10.75%
ROICexc(5y)N/A
ROICexgc(3y)11.84%
ROICexgc(5y)N/A
ROCE(3y)11.72%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y26.78%
ROICexc growth 3YN/A
ROICexc growth 5Y27.82%
OM growth 3YN/A
OM growth 5Y20.36%
PM growth 3YN/A
PM growth 5Y203.85%
GM growth 3Y48.5%
GM growth 5Y10.19%
F-Score8
Asset Turnover0.85
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.36 | ||
| Debt/FCF | 2.58 | ||
| Debt/EBITDA | 0.99 | ||
| Cap/Depr | 120.23% | ||
| Cap/Sales | 5.88% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 62.52% | ||
| Profit Quality | 65.15% | ||
| Current Ratio | 4.44 | ||
| Quick Ratio | 2.37 | ||
| Altman-Z | 9.19 |
F-Score8
WACC9.5%
ROIC/WACC1.65
Cap/Depr(3y)81.81%
Cap/Depr(5y)79.25%
Cap/Sales(3y)4.03%
Cap/Sales(5y)4.77%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)46.33%
EPS 3YN/A
EPS 5Y27.85%
EPS Q2Q%40.46%
EPS Next Y30.75%
EPS Next 2Y25.52%
EPS Next 3Y20.5%
EPS Next 5Y15.01%
Revenue 1Y (TTM)2.4%
Revenue growth 3Y16.15%
Revenue growth 5Y5.7%
Sales Q2Q%2.24%
Revenue Next Year4.4%
Revenue Next 2Y6.66%
Revenue Next 3Y6.85%
Revenue Next 5Y5.66%
EBIT growth 1Y39.58%
EBIT growth 3YN/A
EBIT growth 5Y27.21%
EBIT Next Year52.56%
EBIT Next 3Y26.68%
EBIT Next 5Y27.04%
FCF growth 1Y2796.77%
FCF growth 3YN/A
FCF growth 5Y36.49%
OCF growth 1Y338.96%
OCF growth 3Y318.7%
OCF growth 5Y13.7%
CARPENTER TECHNOLOGY / CRS FAQ
Can you provide the ChartMill fundamental rating for CARPENTER TECHNOLOGY?
ChartMill assigns a fundamental rating of 7 / 10 to CRS.
What is the valuation status of CARPENTER TECHNOLOGY (CRS) stock?
ChartMill assigns a valuation rating of 4 / 10 to CARPENTER TECHNOLOGY (CRS). This can be considered as Fairly Valued.
What is the profitability of CRS stock?
CARPENTER TECHNOLOGY (CRS) has a profitability rating of 8 / 10.
Can you provide the financial health for CRS stock?
The financial health rating of CARPENTER TECHNOLOGY (CRS) is 8 / 10.
How sustainable is the dividend of CARPENTER TECHNOLOGY (CRS) stock?
The dividend rating of CARPENTER TECHNOLOGY (CRS) is 5 / 10 and the dividend payout ratio is 9.75%.